_version_ 1784893080129765376
author Stellato, Mara
Dewenter, Matthias
Rudnik, Michal
Hukara, Amela
Özsoy, Çagla
Renoux, Florian
Pachera, Elena
Gantenbein, Felix
Seebeck, Petra
Uhtjaerv, Siim
Osto, Elena
Razansky, Daniel
Klingel, Karin
Henes, Joerg
Distler, Oliver
Błyszczuk, Przemysław
Kania, Gabriela
author_facet Stellato, Mara
Dewenter, Matthias
Rudnik, Michal
Hukara, Amela
Özsoy, Çagla
Renoux, Florian
Pachera, Elena
Gantenbein, Felix
Seebeck, Petra
Uhtjaerv, Siim
Osto, Elena
Razansky, Daniel
Klingel, Karin
Henes, Joerg
Distler, Oliver
Błyszczuk, Przemysław
Kania, Gabriela
author_sort Stellato, Mara
collection PubMed
description
format Online
Article
Text
id pubmed-9950058
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99500582023-02-25 Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions Stellato, Mara Dewenter, Matthias Rudnik, Michal Hukara, Amela Özsoy, Çagla Renoux, Florian Pachera, Elena Gantenbein, Felix Seebeck, Petra Uhtjaerv, Siim Osto, Elena Razansky, Daniel Klingel, Karin Henes, Joerg Distler, Oliver Błyszczuk, Przemysław Kania, Gabriela Commun Biol Author Correction Nature Publishing Group UK 2023-02-23 /pmc/articles/PMC9950058/ /pubmed/36823451 http://dx.doi.org/10.1038/s42003-023-04600-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Stellato, Mara
Dewenter, Matthias
Rudnik, Michal
Hukara, Amela
Özsoy, Çagla
Renoux, Florian
Pachera, Elena
Gantenbein, Felix
Seebeck, Petra
Uhtjaerv, Siim
Osto, Elena
Razansky, Daniel
Klingel, Karin
Henes, Joerg
Distler, Oliver
Błyszczuk, Przemysław
Kania, Gabriela
Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title_full Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title_fullStr Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title_full_unstemmed Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title_short Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
title_sort author correction: the ap-1 transcription factor fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950058/
https://www.ncbi.nlm.nih.gov/pubmed/36823451
http://dx.doi.org/10.1038/s42003-023-04600-z
work_keys_str_mv AT stellatomara authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT dewentermatthias authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT rudnikmichal authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT hukaraamela authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT ozsoycagla authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT renouxflorian authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT pacheraelena authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT gantenbeinfelix authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT seebeckpetra authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT uhtjaervsiim authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT ostoelena authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT razanskydaniel authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT klingelkarin authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT henesjoerg authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT distleroliver authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT błyszczukprzemysław authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions
AT kaniagabriela authorcorrectiontheap1transcriptionfactorfosl2drivescardiacfibrosisandarrhythmiasunderimmunofibroticconditions